Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19Leora R. Feldstein, Adrienne G. Randolph, Mark W. Tenforde et al.|JAMA|2021Cited by 852
Multisystem Inflammatory Syndrome in Children — Initial Therapy and OutcomesMary Beth F. Son, Adrienne G. Randolph, Nancy L. Murray et al.|New England Journal of Medicine|2021Cited by 380
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescentsAlon Geva, Adrienne G. Randolph, Natasha Halasa et al.|EClinicalMedicine|2021Cited by 35
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020Kerri L. LaRovere, Gwenn E. McLaughlin, Tina Young Poussaint et al.|JAMA Neurology|2022Cited by 27
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US ChildrenNatasha Halasa, Mourani Peter, Andrew J. Spieker et al.|Clinical Infectious Diseases|2022Cited by 20